FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alkermes's Free Cash Flow for the
three
months ended in Dec. 2023 was $90 Mil. Alkermes's Revenue for the
three
months ended in Dec. 2023 was $377 Mil. Therefore, Alkermes's FCF Margin % for the quarter that ended in Dec. 2023 was 23.90%.
The historical rank and industry rank for Alkermes's FCF Margin % or its related term are showing as below:
ALKS'
s FCF Margin % Range Over the Past 10 Years
Min: -14.84 Med: -1.58 Max: 21.24
Current: 21.24
During the past 13 years, the highest FCF Margin % of Alkermes was 21.24%. The lowest was -14.84%. And the median was -1.58%.
ALKS's FCF Margin % is ranked better than 92.01% of 1026
companies
in the Drug Manufacturers industry
Industry Median: -0.68
vs ALKS: 21.24
Alkermes FCF Margin % Historical Data
The historical data trend for Alkermes's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Alkermes's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alkermes's FCF Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alkermes's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Alkermes's FCF Margin % falls into.
Alkermes FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Alkermes's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alkermes FCF Margin % Related Terms
Thank you for viewing the detailed overview of Alkermes's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALKS has been successfully added to your 